Neuroendocrine carcinoma of the breast - a pilot study of a Danish population of 240 breast cancer patients

Autor: Maj-Lis Møller Talman, Vera Timmermans Wielenga, Julie Benedicte Brask

Publikováno v: APMIS. 122:585-592

Neuroendocrine carcinoma of the breast - a very recent diagnosis, which was not recognized by WHO until 2003 - has lately been the subject of increasing attention. It is defined as a primary breast cancer with morphologic features similar to other ty

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e68070e6afcb03e5e2d86394f733ce6c
https://doi.org/10.1111/apm.12197

Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response

Autor: Renée Foekens, Maxime P. Look, Fred C.G.J. Sweep, Julie Benedicte Brask, Anita M. A. C. Trapman-Jansen, Paul N. Span, Reno Debets, Robin Beekhof, Tommaso De Marchi, Carolien H.M. van Deurzen, Vera Timmermans-Wielenga, John A. Foekens, Ning Qing Liu, John W.M. Martens, Annemieke M. Timmermans, Arzu Umar

Publikováno v: Molecular & Cellular Proteomics, 13, 1814-27
Molecular & Cellular Proteomics, 13(7), 1814-1827. American Society for Biochemistry and Molecular Biology Inc.
Molecular & Cellular Proteomics, 13, 7, pp. 1814-27
Molecular & Cellular Proteomics : MCP

Item does not contain fulltext Ferritin heavy chain (FTH1) is a 21-kDa subunit of the ferritin complex, known for its role in iron metabolism, and which has recently been identified as a favorable prognostic protein for triple negative breast cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c3551aa93665c17d55950762bb8e703
https://doi.org/10.1074/mcp.M113.037176

Tissue microarray analysis as a screening tool for neuroendocrine carcinoma of the breast.

Autor: Brask, Julie Benedicte¹, Talman, Maj‐Lis Møller¹, Wielenga, Vera Timmermans¹

Publikováno v: APMIS. Jul2014, Vol. 122 Issue 7, p593-598. 6p.